Zobrazeno 1 - 10 of 136 pro vyhledávání: '"M. Averbuch"'
3
Gender and the placebo analgesic effect in acute pain
Autor: M. Katzper, M. Averbuch
Publikováno v: Clinical Pharmacology & Therapeutics. 70:287-291
Objective Our objective was to examine the placebo arms from a series of clinical trials in which the post–third molar extraction dental pain model was used to elucidate the time course of the placebo effect and the proportion of the population tha
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36c9b5f22da0f9133acaec1e4a003def
https://doi.org/10.1067/mcp.2001.118366
Zobrazit plný text záznamu
4
Understanding and treating arm movement impairment after chronic brain injury: progress with the ARM guide
Autor: D J, Reinkensmeyer, L E, Kahn, M, Averbuch, A, McKenna-Cole, B D, Schmit, W Z, Rymer
Publikováno v: Journal of rehabilitation research and development. 37(6)
Significant potential exists for enhancing physical rehabilitation following neurologic injury through the use of robotic and mechatronic devices (or "rehabilitators"). We review the development of a rehabilitator (the "ARM Guide") to diagnose and tr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7725ac4bf4b4ef6da024ec4830c6487c
https://pubmed.ncbi.nlm.nih.gov/11321001
Zobrazit plný text záznamu
6
Hormone replacement and simvastatin in the therapy of hypercholesterolemic postmenopausal women
Autor: M, Averbuch, D, Ayalon, N, Eckstein, I, Dotan, I, Shapira, Y, Levo, A, Pines
Publikováno v: Journal of medicine. 29(5-6)
To prospectively investigate the effect of cholesterol lowering diet, hormone replacement therapy and simvastatin on plasma lipid levels using a 3-month stepwise protocol.Participants were postmenopausal women under the age of 60 with hypercholestero
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a00f5d04a6ca8929230da998f238b6bb
https://pubmed.ncbi.nlm.nih.gov/10503169
Zobrazit plný text záznamu
7
Long-term weight control study. V (weeks 190 to 210). Follow-up of participants after cessation of medication
Autor: M, Weintraub, P R, Sundaresan, B, Schuster, M, Averbuch, E C, Stein, L, Byrne
Publikováno v: Clinical pharmacology and therapeutics. 51(5)
Participants who completed up to week 190 in the long-term weight control study were monitored after cessation of medication between weeks 190 and 210. Caloric restriction, behavior modification sessions, exercise reinforcement, and physician visits
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d89b8c082575714cfc2135439d6bab9e
https://pubmed.ncbi.nlm.nih.gov/1587076
Zobrazit plný text záznamu
8
Long-term weight control study. IV (weeks 156 to 190). The second double-blind phase
Autor: M, Weintraub, P R, Sundaresan, B, Schuster, M, Averbuch, E C, Stein, C, Cox, L, Byrne
Publikováno v: Clinical pharmacology and therapeutics. 51(5)
To assess continued efficacy of anorexiants after 3 years of use, 52 participants (43% of those starting) entered a second double-blind trial to compare 60 mg sustained-release fenfluramine plus 15 mg phentermine resin versus placebo added to behavio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::721526425bb298ff9bfcdec33fdcc4a0
https://pubmed.ncbi.nlm.nih.gov/1587075
Zobrazit plný text záznamu
10
[Sedural toxicity]
Autor: R, Kornowski, M, Averbuch, A, Jaffe, D, Schwartz, Y, Levo
Publikováno v: Harefuah. 120(6)
Phenazopyridine (Sedural) is widely used in the treatment of dysuria. It is considered a benign drug and most physicians are unaware of its potential toxicity. A 24-year-old woman who developed methemoglobinemia, acute renal failure and hemolytic ane
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ff1a57167db6c9c40777a2570eb699c2
https://pubmed.ncbi.nlm.nih.gov/1879765
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje